33.54

2.37% 0.775

Pre-market: 32.86 -0.68 -2.03%

Vtv Therapeutics Inc (VTVT)

Overview News Price History Financials Discussions Forecast

Vtv Therapeutics Inc stock is traded at $33.54, with a volume of 52,212. It is up +2.37% in the last 24 hours and down -6.04% over the past month. vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Previous Close:

$32.77

Open:

$33.46

24h Volume:

52,212

Relative Volume:

1.01

Market Cap:

$132.10M

Revenue:

$36.84M

Net Income/Loss:

$-729.00K

P/E Ratio:

-36.31

EPS:

-0.9237

Net Cash Flow:

$-10.02M

1W Performance:

+4.62%

1M Performance:

-6.04%

6M Performance:

-0.65%

1Y Performance:

+118.50%

1-Day Range:

$32.13

$33.75

1-Week Range:

$30.41

$33.75

52-Week Range:

$14.00

$44.00

Vtv Therapeutics Inc Stock (VTVT) Company Profile

Name

Vtv Therapeutics Inc

Sector

Healthcare (1104)

Industry

Biotechnology (621)

Phone

336-841-0300

Address

3980 PREMIER DR, HIGH POINT, NC

Employee

Twitter

@vTvTherapeutics

Next Earnings Date

2026-05-21

Latest SEC Filings

VTVT's Discussions on Twitter

Compare VTVT vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VTVT Vtv Therapeutics Inc	33.54	132.10M	36.84M	-729.00K	-10.02M	-0.9237
VRTX Vertex Pharmaceuticals Inc	450.46	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.98	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	884.20	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	287.80	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	160.06	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Initiated	Evercore ISI	Outperform
Jan-23-26	Initiated	Roth Capital	Buy
Jan-05-26	Initiated	TD Cowen	Buy
Nov-19-25	Initiated	BTIG Research	Buy
May-30-19	Initiated	H.C. Wainwright	Buy
Apr-10-18	Downgrade	Stifel	Buy → Hold
Mar-08-18	Initiated	ROTH Capital	Buy
Feb-08-18	Initiated	Northland Capital	Outperform
Sep-26-16	Initiated	H.C. Wainwright	Buy
Sep-04-15	Initiated	Canaccord Genuity	Buy
Aug-24-15	Initiated	Piper Jaffray	Overweight
Aug-24-15	Initiated	Stifel	Buy

View All

Vtv Therapeutics Inc Stock (VTVT) Latest News

Jun 09, 2026

VTVT Q1 2026 Earnings: Surprise Profit Amid No RevenueEarnings Preview - newsline.com

Jun 09, 2026

Jun 08, 2026

Price-Driven Insight from (VTVT) for Rule-Based Strategy - Stock Traders Daily

Jun 08, 2026

Jun 06, 2026

vTv Therapeutics, Inc. Class A Financial Disclosures & SEC Filings - TradingView

Jun 06, 2026

VTVT Q1 2026 Earnings: Massive EPS Beat Driven by Non-Operational ItemsForward EPS Estimate - newsline.com

Jun 06, 2026

Jun 05, 2026

VTVT Technical Analysis | Trend, Signals & Chart Patterns | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill

Jun 05, 2026

Jun 02, 2026

Stock options, 10-year term: inside vTv Therapeutics grant - Stock Titan

Jun 02, 2026

Jun 01, 2026

VTVT Stock Price, Quote & Chart | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill

Jun 01, 2026

May 31, 2026

MSN Money - MSN

May 31, 2026

May 29, 2026

vTv Therapeutics Drops as Diabetes Study Date Approaches - Bez Kabli

May 29, 2026

May 28, 2026

vTv Therapeutics (VTVT) Edges Lower, Holding Above Key Support Amid ConsolidationRisk Parity Rebalance - thelegaladvocate.com

May 28, 2026

(VTVT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

May 28, 2026

May 27, 2026

VTVT Q1 2026 Earnings: Massive EPS Surprise Driven by a Non-Recurring GainEarnings Quality Score - The Legal Advocate

May 27, 2026

May 26, 2026

VTVT Q1 2026 Earnings: Massive EPS Beat Driven by One-Time Items, Stock DeclinesCEO Earnings Statement - The Legal Advocate

May 26, 2026

May 25, 2026